Search clinical trials for: TransCon Treprostinil

Total 153 results

Inova Health Care Services

Terminated

Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso

Chronic Obstructive Pulmonary Disease (COPD)

United States
United Therapeutics

Completed

Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin

Pulmonary Hypertension

United States
United Therapeutics

Completed

Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil

Pulmonary Arterial Hypertension | Hypertension, Pulmonary

United States
Ascendis Pharma Oncology Division A/S

Recruiting

TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma (BelieveIT-201)

Head and Neck Neoplasms

United States, Spain, Georgia, Hungary, Germany, Italy, Taiwan
United Therapeutics

Completed

A Pharmacokinetic Substudy of the TDE-PH-304 Protocol

Pulmonary Arterial Hypertension

United States
Bial - Portela C S.A.

Completed

Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil

Pulmonary Arterial Hypertension

Germany
United Therapeutics

Terminated

Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH

Pulmonary Arterial Hypertension

United States
Pharmosa Biopharm Inc.
PPD

Completed

Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606

Pulmonary Arterial Hypertension

United States
Ascendis Pharma Endocrinology Division A/S

Completed

A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

Endocrine System Diseases | Pituitary Diseases | Hormones | Growth Hormone Deficiency, Pediatric | hGH (Human Growth Hormone)

United States, Armenia, Australia, Belarus, Bulgaria, Georgia, Greece, Italy, New Zealand, Poland, Romania, Russian Federation, Turkey, Ukraine
Magdi H. Yacoub

Recruiting

Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension

Pulmonary Hypertension

Egypt
United Therapeutics
University of Pittsburgh Medical Center

Withdrawn

Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients

Liver Transplant

United States
University of Arizona

Unknown

Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH

Pulmonary Arterial Hypertension

United States
Visen Pharmaceuticals (Shanghai) Co., Ltd.
Ascendis Pharma A/S

Unknown

Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency

Endocrine System Diseases | Pituitary Diseases | Growth Hormone Deficiency | Hormones | Pituitary Disease, Anterior

China
United Therapeutics

Completed

Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) (TRIUMPH)

Pulmonary Hypertension

United States, Israel, Austria, United Kingdom, Belgium, France, Germany, Ireland, Italy, Spain
United Therapeutics

Completed

Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID) (RAPID)

Pulmonary Arterial Hypertension
Jewish General Hospital

Withdrawn

Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain

Pulmonary Arterial Hypertension

Canada
Rajan Saggar
United Therapeutics

Completed

Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension

Idiopathic Pulmonary Fibrosis | Pulmonary Arterial Hypertension | Interstitial Lung Disease

United States
Baylor College of Medicine
Electrochemical Oxygen Concepts, Inc.

Recruiting

Continuous Diffusion of Oxygen Treatment for Incision Wounds

Breast Surgery | Surgical Wound | Mammoplasty | Incision Wound

United States
Baylor College of Medicine
Electrochemical Oxygen Concepts, Inc.

Recruiting

EO2 Oxygen Delivery To Study Success Rate of Surgically Closed Wounds

Diabetes | Diabetic Foot | Breast Cancer | Peripheral Arterial Disease | Surgical Wound | Amputation Wound | Incision Wound

United States
United Therapeutics

Completed

Remodulin® to Oral Treprostinil Transition

Pulmonary Arterial Hypertension

United States
United Therapeutics
University of California, Los Angeles; Emory University; Brigham and Women's... and other collaborators

Completed

A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension

Pulmonary Arterial Hypertension | Pulmonary Hypertension | Portopulmonary Hypertension

United States
Stanford University
Northwestern University

Completed

A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).

Hypertension, Pulmonary

United States
Stanford University

Terminated

Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation

Single Ventricle

United States
Hospices Civils de Lyon

Terminated

Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin

Coronary and Peripheral Endothelial Dysfunction

France
Rhode Island Hospital
United Therapeutics; University of Rhode Island

Recruiting

Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation

Ischemia Reperfusion Injury | Delayed Graft Function

United States
University of Pennsylvania

Completed

Screened Health Assessment & Pacer Evaluation

Obesity
Abhinav Humar, MD

Completed

Safety and Efficacy of Treprostinil in Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplantation

Ischemia Reperfusion Injury

United States
Lundquist Institute for Biomedical Innovation at...
United Therapeutics

Completed

Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication

Pulmonary Arterial Hypertension

United States
Ascendis Pharma Oncology Division A/S

Recruiting

A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors

Advanced Solid Tumor | Metastatic Solid Tumor | Locally Advanced Solid Tumor | Neoadjuvant Melanoma | Head and Neck Squamous Cell Carcinoma HNSCC | HPV-associated Cancers | Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)

United States, Australia, Spain, Netherlands, Korea, Republic of, Taiwan
Foundation University Islamabad

Active, not recruiting

Nano Composites and Light Cure Composites - A Comparative Assessment of Bond Failure Rates

Nanotechnology, Dental Materials, Composites

Pakistan
Mayo Clinic
United Therapeutics

Enrolling by invitation

A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension

Pulmonary Arterial Hypertension | Interstitial Lung Disease | Healthy Adults

United States
Somnetics International, Inc.

Completed

Transcend Auto Clinical Evaluation

Obstructive Sleep Apnea

United States
University of Heidelberg Medical Center
Heidelberg Engineering GmbH

Recruiting

Evaluation of Optical Coherence Tomography in Dentistry

Dental Caries | Tooth Demineralization

Germany
Children's Hospital Medical Center, Cincinnati

Terminated

Acute Effects of Inhaled Treprostinil in Fontan Patients

Congenital Heart Disease

United States
United Therapeutics

Active, not recruiting

Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin (EVOLVE)

Pulmonary Arterial Hypertension

United States
Ascendis Pharma A/S

Completed

Pharmacokinetics and Pharmacodynamics of ACP-001 (TransCon PEG hGH)

Healthy

Canada
United Therapeutics

Completed

Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers (TDE-PH-125)

Healthy

United States
Boston Medical Center
Deborah Munroe Noonan Memorial Research Fund

Recruiting

Transitioning Together Boston

Family Relations | Autism or Autistic Traits

United States
Medtronic Cardiac Rhythm and Heart Failure
United Therapeutics

Active, not recruiting

DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study (DelIVery)

Pulmonary Arterial Hypertension

United States
Eli Lilly and Company

Completed

A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants

Healthy

Japan
Electrochemical Oxygen Concepts, Inc.

Completed

A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers

Diabetic Foot Ulcer

United States
United Therapeutics

Withdrawn

FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

Pulmonary Hypertension

United States, Australia, Mexico
United Therapeutics

Completed

Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies (Aspire)

Pulmonary Arterial Hypertension

United States
United Therapeutics

Terminated

Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn

Persistent Pulmonary Hypertension of the Newborn

United States
Sheffield Teaching Hospitals NHS Foundation Trust

Completed

RMGI v Composite for Orthodontic Bonding

Malocclusion

Ireland, United Kingdom
Targacept Inc.

Completed

A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)

Age-Related Memory Disorders

United States
Mahidol University

Completed

Efficacy of Low-dose Intra-articular Tranexamic Acid in Total Knee Replacement

Primary Osteoarthritis of Knee Nos

Thailand
Metabolic Research Unit

Enrolling by invitation

ORAL ANTIDIABETICS EFFECT ON VISCERAL FAT

Type 2 Diabetes | Abdominal Obesity

Mexico
Eli Lilly and Company

Completed

A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Novo Nordisk A/S

Completed

Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes (LIRA-PRIME)

Diabetes Mellitus, Type 2 | Diabetes

United States, Canada, Serbia, Turkey, Russian Federation, India, Latvia, Puerto Rico, Lebanon, Colombia

Search clinical trials for: TransCon Treprostinil

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations